help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gyi, K. K.
Right arrow Articles by Wrathall, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gyi, K. K.
Right arrow Articles by Wrathall, J. R.

American Journal of Pathology, Vol 110, 135-147, Copyright © 1983 by American Society for Investigative Pathology

REGULAR ARTICLES

Histopathology and host response associated with reduced tumorigenicity of 5-bromodeoxyuridine--treated murine melanoma cells

KK Gyi and JR Wrathall

Growth of B16 murine melanoma cells (clone B559) with low concentrations of 5-bromodeoxyuridine (BrdUrd) has previously been shown to have little effect upon cell proliferation in culture but to significantly reduce the tumorigenicity of the cells when they are injected into adult syngeneic mice. To determine the fate of BrdUrd- grown cells in vivo, we compared the sites of injection of control, fully tumorigenic B559 cells, and BrdUrd-grown cells (3 micrograms/ml for 3 days, termed 3BRM cells) with greatly reduced tumorigenicity (only 8%). We found no evidence of even a transitory period of progressive growth in vivo of BrdUrd-grown cells. At sites of injection of 3BRM cells, as early as Day 1 after injection, there was a significantly lower proliferation rate of the melanoma cells, significantly greater numbers of infiltrating host mononuclear cells, and a significantly higher ratio of host mononuclear to melanoma cells. There was no evidence of endothelial cell proliferation or neovascularization at the sites of 3BRM cells. When sites of injection at 1 day after injection were examined electron-microscopically, evidence of host melanoma cell interactions was more frequently observed at sites of 3BRM cells. The results suggest that the reduced tumorigenicity of BrdUrd-grown melanoma cells may be due to cytostatic and/or cytotoxic influences generated by an enhanced mononuclear cell response. Because the host response occurs so quickly, the involvement of natural killer cells is postulated.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Society for Investigative Pathology.